About
Annaida Technologies is a Swiss company founded in 2018 by Marco and Gora, who are passionate about physics, microtechnology, and life sciences. The company is named in honor of their grandmothers, Anna and Ida. Annaida focuses on advancing the measurement and analysis of microscopic life through precise, non-invasive methods. The flagship product, EmbryoSpin, utilizes microscopic Nuclear Magnetic Resonance (μNMR) technology, offering sensitivity ten times better than existing methods. This device enables non-invasive chemical analysis at the scale of a single human embryo, enhancing assisted reproductive technology (ART) by facilitating embryo viability screening in in vitro fertilization (IVF). EmbryoSpin is also applicable in biochemical research. Annaida Technologies aims to simplify and improve the analysis of microscopic life, contributing to better clinical outcomes, drug development, and scientific discovery. The company maintains a strong Quality Management System (QMS) to ensure high standards in its products and services, and it collaborates closely with academic institutions to further its research and development efforts.
Technologies
Keywords
Company Information
-
Employees 9
-
Founded 2019
-
Annual Revenue $1000000
-
Total Funding $1128911
Location
Lausanne, Vaud, Switzerland, 1003